Aventis contributes $1 million to Red Cross

February 2002
Pest Control;Feb2002, Vol. 70 Issue 2, p60
Trade Publication
Reports the assistance of Aventis to the American Red Cross for the ongoing relief efforts following the terrorist attacks in Montvale, New Jersey.


Related Articles

  • Sanofi Launches Cut-Price Malaria Pill for Africa. Kaye, Donald // Clinical Infectious Diseases;5/1/2007, Vol. 44 Issue 9, piii 

    The article pertains to a medicinal pill against malaria which is developed by French drugmaker Sanofi-Aventis SA. It's said to be a low cost pill specially made to fight the disease in Africa. The company is said to have joined hands with the Drugs for Neglected Diseases initiative, a charity...

  • Be an angel.  // Good Health (Australia Edition);Jun2011, p18 

    The article offers information on the charity program started by Sanofi-Aventis SA under which money from every sale of its Nature's Own Multivitamins or Fish Oil product will be donated to the international organisation dedicated to reducing child mortality Vitamin Angels.

  • ETHYPHARM TO DEVELOP A FLASH VERSION OF AVENTIS' ALLEGRA.  // Worldwide Biotech;Jul2002, Vol. 14 Issue 7, p6 

    Reports on a licensing agreement signed by Ethypharm with Aventis.

  • Sanofi: Time not right to sell off beauty unit.  // WWD: Women's Wear Daily;9/8/1997, Vol. 174 Issue 48, p4 

    Focuses on pharmaceuticals and beauty products company, Sanofi's executive vice president for administration and finance, Jean-Paul Leon's issuance of a statement to clarify French business newspapers report that the company is planning to sell off its beauty division. Overview on Sanofi's...

  • Retork completes system upgrade at Aventis plant.  // Life Science Today;Jun2000, Vol. 1 Issue 3, p2 

    Focuses on the completion of the end control system project by Rotork Control and Safety at the Aventis research facility. Expansion of the pilot-scale control system; Importance of Good Automated Manufacturing Practice guidelines for the ownership of the project; Start-up problems of the project.

  • Aventis promotes improved Dr. Chart program, MyDocOline software. Arnold, Matthew // Medical Marketing & Media;May2003, Vol. 38 Issue 5, p30 

    Reports on Aventis Inc.'s upgrade of its MyDocOnline software suite with the launch of Practice Solutions software. Automation of billing and prescribing functions; Expansion of the Dr. Chart program; Efforts to improve patient compliance.

  • Aventis Streamlines R&D. Houlton, Sarah // Pharmaceutical Executive;Sep2002, Vol. 22 Issue 9, p21 

    Reports on Aventis' plan to reduce its research and development costs by spinning out a stake in one of its research units. Plans of the private equity house Warburg Pincus to invest in ProSkelia; Aventis' plan to spin off its gene therapy unit, Gencell.

  • Beauty sales at Sanofi decline 2%.  // WWD: Women's Wear Daily;4/14/1995, Vol. 169 Issue 72, p9 

    Reports on the decline in sales of Sanofi SA's beauty products and fragrances during the first quarter of 1995.

  • Place your bets. Hawking, Stephen // New Scientist;6/22/2002, Vol. 174 Issue 2348, p50 

    Focuses on the Science Book Prize sponsored by Aventis. Citation of past winners; List of nominees; Details on several research cited by judges.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics